You've heard a lot about Ozempic and Wegovy but what's the difference? Here's a comparison of the medications Wegovy and Ozempic:
Wegovy: It is approved by the U.S. Food and Drug Administration (FDA) for chronic weight
management in adults with a body mass index (BMI) of 30 kg/m² or greater, or in adults with a BMI of 27 kg/m² or greater who have at least one weight-related comorbidity (such as hypertension, type 2 diabetes, or dyslipidemia).
Ozempic: It is indicated for the treatment of type 2 diabetes in adults, along with diet and exercise.
Wegovy: The active ingredient in Wegovy is semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide is a synthetic form of the human hormone GLP-1.
Ozempic: The active ingredient in Ozempic is also semaglutide, the same as Wegovy. Therefore, in terms of active ingredients, Wegovy and Ozempic are the same.
Dosage and Administration:
Wegovy: It is available as a subcutaneous injection and is administered once weekly. Starting at 0.25 mg to 2.4 mg.
Ozempic: It is also administered as a subcutaneous injection but has a once-weekly dosing regimen. Doses start at 0.25 to 2 mg.
Weight Loss Effects:
Wegovy: Clinical trials have shown that Wegovy leads to significant weight loss in individuals who are overweight or have obesity, with an average loss of about 10%. In studies, patients treated with Wegovy demonstrated greater weight loss compared to those treated with a placebo.
Ozempic: While Ozempic is primarily indicated for type 2 diabetes management, it has also shown weight loss effects. Patients with type 2 diabetes treated with Ozempic have experienced weight reduction as a secondary effect.
It's important to note that both Wegovy and Ozempic are prescription medications, and their use should be under the supervision and guidance of a healthcare professional. The suitability of these medications for an individual should be assessed based on their specific health conditions, medical history, and goals.